GSK Stock Analysis Overview . Chief Scientific Officer, Pres of R&D and Director, Sr. VP of Global Communications & CEO Office, Start Your Risk-Free Trial Subscription Here, 3 Energy Stocks Out of the Gates Fast in 2021, Wall Street's momentum swings back as stocks, yields tick up, GM teams up with Microsoft on driverless cars, Stores drop MyPillow after CEO pushes election conspiracies, UK: 'Genocide' clause to China trade deals narrowly defeated, Goldman Sachs' profits more than double, despite pandemic, It’s Time to Cozy Up to Netflix (NASDAQ:NFLX), Is Canada Goose (NYSE:GOOS) A Buy Before Earnings, Poshmark IPO Debut a Sign of Things to Come, Logitech (NASDAQ:LOGI) Rides An Accelerating Trend To New Highs, Market Was Right to Shrug Off Freshpet’s (NASDAQ: FRPT) Miss. 150,004 shares of the stock were exchanged, compared to its average … GlaxoSmithKline PLC Stock Forecast Over the next 52 weeks, GlaxoSmithKline PLC has on average historically risen by 15 % based on the past 44 years of stock performance. ), GlaxoSmithKline has received 1,115 “underperform” votes. One share of GSK stock can currently be purchased for approximately $38.54. With a 5-year investment, the revenue is expected to be around +34.32%. All rights reserved. A rank of 34 means that 66% of stocks appear more favorable to our system. A Warner Media Company. On average, they expect GlaxoSmithKline plc (GSK.L)'s stock price to reach GBX 1,763 in the next twelve months. Fortunes will be made and lost in 2021 – and you likely have just weeks to decide which side you’ll be on. The pharmaceutical company earned $11.17 billion during the quarter, compared to analyst estimates of $11.27 billion. GlaxoSmithKline has received 59.34% “underperform” votes from our community. PEG Ratios above 1 indicate that a company could be overvalued. Price Target Glaxosmithkline Plc's stock had its IPO on July 9, 1986, making it an older stock than 92.32% of US equities in our set. GlaxoSmithKline pays an annual dividend of $2.04 per share and currently has a dividend yield of 5.30%. View all of GSK's competitors. GlaxoSmithKline PLC is a global healthcare company. According to 6 analysts, the average rating for GSK stock is "Buy." GSK stock was acquired by a variety of institutional investors in the last quarter, including Galibier Capital Management Ltd., Douglas Lane & Associates LLC, Gilman Hill Asset Management LLC, Jacobs & Co. CA, SevenBridge Financial Group LLC, Bonness Enterprises Inc., Signature Wealth Management Group, and Crescent Capital Consulting LLC. With a 5-year investment, the revenue is expected to be around +8.55%. Based on aggregate information from My MarketBeat watchlists, some companies that other GlaxoSmithKline investors own include AT&T (T), Pfizer (PFE), Johnson & Johnson (JNJ), Verizon Communications (VZ), Cisco Systems (CSCO), AbbVie (ABBV), Intel (INTC), Gilead Sciences (GILD), The Walt Disney (DIS) and NVIDIA (NVDA). Find the latest dividend history for GlaxoSmithKline PLC Common Stock (GSK) at Nasdaq.com. GlaxoSmithKline PLC is estimated to report earnings on 02/03/2021. Next Steps Explore strong dividend paying … Learn about financial terms, types of investments, trading strategies and more. However, solely looking at the historical price movement is usually misleading. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. Learn everything you need to know about successful options trading with this three-part video course. View our earnings forecast for GlaxoSmithKline. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend … (Add your “outperform” vote. GlaxoSmithKline's stock was trading at $39.87 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Glaxosmithkline Plc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. See what's happening in the market right now with MarketBeat's real-time news feed. However, solely looking at the historical price movement is usually misleading. Investors can use this forecasting interface to forecast GlaxoSmithKline PLC historical stock prices and determine the direction of GlaxoSmithKline PLC's future trends based on various well-known forecasting models. Wall Street analysts have given GlaxoSmithKline a "Hold" rating, but there may be better short-term opportunities in the market. The Company operates through two segments: Pharmaceuticals and Vaccines. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Given the current horizontal trend, you can expect GlaxoSmithKline PLC stock with a 90% probability to be traded between $33.98 and $39.74 at the end of this 3-month period. GlaxoSmithKline's mailing address is 980 GREAT WEST ROAD, BRENTFORD X0, TW8 9GS. Do Not Sell My Information. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Export data to Excel for your own analysis. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Get Our PREMIUM Forecast Now, from ONLY $6.69! Based on our forecasts, a long-term increase is expected, the "GSK" stock price prognosis for 2025-12-23 is 1802.630 GBX. During the day the stock fluctuated 0.76% from a day low at $37.56 to a day high of $37.84. Vote “Underperform” if you believe GSK will underperform the S&P 500 over the long term. The Company makes a range of prescription medicines and vaccines … There is not enough analysis data for GlaxoSmithKline. Looking for new stock ideas? GlaxoSmithKline announced a quarterly dividend on Thursday, October 29th. Climbing the patent cliff. Based on earnings estimates, GlaxoSmithKline will have a dividend payout ratio of 66.23% next year. The firm has a market capitalization of $96.65 billion, a price-to-earnings ratio of 11.82, a price-to-earnings-growth ratio of 2.93 and a beta of 0.67. All rights reserved. The Glaxosmithkline plc - ADR stock forecast is 70.847354 USD for 2022 January 16, Sunday; and 267.671 USD for 2026 January 16, Friday with technical analysis. This payout ratio is at a healthy, sustainable level, below 75%. Glaxosmithkline plc - ADR (GSK) stock price prediction is 70.847354 USD. GlaxoSmithKline had a net margin of 18.50% and a return on equity of 29.60%. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Learn more. View which stocks have been most impacted by COVID-19. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. GSK Stock is A bit Undervalued RIght now.. Institutions have price targets of 42~-48 back on the Covid-low-trendline .. View GlaxoSmithKline's dividend history. Glaxosmithkline's earnings in 2019 is $6,111,842,105.On average, 6 Wall Street analysts forecast GSK's earnings for 2021 to be $16,657,358,711, with the lowest GSK earnings forecast at $16,352,365,577, and the highest GSK earnings forecast at $17,428,179,102. Identify stocks that meet your criteria using seven unique stock screeners. 19 brokers have issued 1 year price objectives for GlaxoSmithKline plc (GSK.L)'s shares. CNN Sans™ & © 2016 Cable News Network. Earnings for GlaxoSmithKline are expected to grow by 0.33% in the coming year, from $3.07 to $3.08 per share. GSK has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. This payout ratio is at a healthy, sustainable level, below 75%. Learn more. Factset: FactSet Research Systems Inc.2019. Get short term trading ideas from the MarketBeat Idea Engine. Get Our PREMIUM Forecast Now, from ONLY $6.69! GlaxoSmithKline employs 99,437 workers across the globe. You can opt out at any time. gsk $38.47 $0.31 0.8% Price as of January 15, 2021, 9:00 p.m. EST View Interactive GSK Charts GLAXOSMITHKLINE PLC : Forcasts, revenue, earnings, analysts expectations, ratios for GLAXOSMITHKLINE PLC Stock | GSK | GB0009252882 I dont see much Downside as Compared to upside. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. The P/E ratio of GlaxoSmithKline is 11.86, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 35.43. © American Consumer News, LLC dba MarketBeat® 2010-2021. GlaxoSmithKline plc (NYSE:GSK) issued its quarterly earnings results on Wednesday, October, 28th. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GSK, but not buy additional shares or sell existing shares. Your current $100 investment may be up to $108.55 in 2026. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. GSK Stock Summary. This suggests a possible upside of … GlaxoSmithKline Pharmaceuticals Target Share Price - Get the latest GlaxoSmithKline Pharmaceuticals share price forecast, Target share price, Stock Quotes, GlaxoSmithKline Pharmaceuticals Stock Analysis, Charts on The Economic Times. What this means: InvestorsObserver gives Glaxosmithkline Plc (GSK) an overall rank of 33, which is below average. To see all exchange delays and terms of use please see disclaimer. GSK’s share price has fallen by nearly 25% so far this year. It has collaboration agreements with 23andMe; Merck KGaA; Lyell Immunopharma; CEPI; Innovax and Xiamen University; VBI; Viome; Sanofi SA; CureVac; and research collaboration with Sengenics focusing on immunology. Some companies that are related to GlaxoSmithKline include Roche (RHHBY), Novartis (NVS), Merck & Co., Inc. (MRK), Pfizer (PFE), Abbott Laboratories (ABT), AbbVie (ABBV), Eli Lilly and (LLY), Novo Nordisk A/S (NVO), Bristol-Myers Squibb (BMY), AstraZeneca (AZN), Sanofi (SNY), CSL (CSLLY), Zoetis (ZTS), Vertex Pharmaceuticals (VRTX) and Bayer Aktiengesellschaft (BAYRY). Shares of GSK can be purchased through any online brokerage account. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Glaxosmithkline Plc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. See GlaxoSmithKline PLC (GSK) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. GlaxoSmithKline's stock is owned by many different institutional and retail investors. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. There are currently 2 sell ratings, 5 hold ratings and 6 buy ratings for the stock. Ralph Lauren (NYSE: RL) Has Room To Run Another 30%, 3 Grocery Store Stocks to Put in Your Cart, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, Receive Analysts' Upgrades and Downgrades Daily. Your current $100 investment may be up to $134.32 in 2026. All rights reserved. We don’t hear much about the patent cliff anymore, but it’s still a real … Only 11.83% of the stock of GlaxoSmithKline is held by institutions. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. The average price target represents a -100.00% upside from the last price of $36.80. Only 10.00% of the stock of GlaxoSmithKline is held by insiders. GlaxoSmithKline does not yet have a strock track record of dividend growth. Receive a free world-class investing education from MarketBeat. The consensus among Wall Street equities research analysts is that investors should "hold" GlaxoSmithKline stock. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. Based on our forecasts, a long-term increase is expected, the "GSK" stock price prognosis for 2025-12-23 is 39.945 USD. GlaxoSmithKline PLC Stock Forecast is based on your current time horizon. The 12-month stock price forecast is 48.50, which is an increase of 26.07% from the latest price. GSK updated stock price target summary. View our full suite of financial calendars and market data tables, all for free. Glaxosmithkline stock was originally listed at a price of $47.88 in Dec 31, 1997. The GlaxoSmithKline PLC stock price gained 0.59% on the last trading day (Wednesday, 13th Jan 2021), rising from $37.46 to $37.68. GlaxoSmithKline's stock was trading at $39.87 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). GSK stock traded up $0.12 during mid-day trading on Tuesday, hitting $38.59. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. The dividend payout ratio of GlaxoSmithKline is 64.35%. (Add your “underperform” vote.). The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency v irus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. This represents a $1.98 dividend on an annualized basis and a yield of 5.15%. GlaxoSmithKline has a PEG Ratio of 2.93. GlaxoSmithKline is a leading dividend payer. 323,181 shares of the stock traded hands, compared to its average volume of 4,043,910. View institutional ownership trends for GlaxoSmithKline. If you had invested in Glaxosmithkline stock at $47.88, your return over the last 23 years would have been -19.92%, for an annualized return of -0.96%. Want to see which stocks are moving? Sign-up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. The Next Few Weeks Could Decide Your Wealth in ‘21. GLAXOSMITHKLINE PLC earnings per share revisions and analysts forecast | London Stock Exchange: GSK | London Stock Exchange GlaxoSmithKline PLC (GSK:LSE) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. View insider buying and selling activity for GlaxoSmithKline or or view top insider-buying stocks. Fundamental company data provided by Morningstar and Zacks Investment Research. All Rights Reserved. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. View which stocks are hot on social media with MarketBeat's trending stocks report. Get daily stock ideas top-performing Wall Street analysts. 13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for GlaxoSmithKline in the last year. The dividend payout ratio of GlaxoSmithKline is 64.35%. Since then, GSK stock has decreased by 7.2% and is now trading at $36.98. GlaxoSmithKline's management team includes the following people: Biden’s New Plan – What No One is Telling You. Is the Beyond Meat (NASDAQ: BYND) Rally Sustainable? The P/E ratio of GlaxoSmithKline is 11.86, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 23.54. With Covid vaccine News coming any day now - … Dip below 35.99 ~ 35.70 range Twice , back up to 36.30 <---- 50+ cent gap ups. GlaxoSmithKline has received 764 “outperform” votes. Their forecasts range from GBX 1,300 to GBX 2,240. The pharmaceutical company can be reached via phone at 44-20-8047-5000 or via email at [email protected]. View analyst ratings for GlaxoSmithKline or view MarketBeat's top 5 stock picks. This price target is based on 12 analysts offering 12 month price targets for GlaxoSmithKline in the last 3 months. It pays a dividend yield of 5.30%, putting its dividend yield in the top 25% of dividend-paying stocks. This indicates that GlaxoSmithKline will be able to sustain or increase its dividend. The pharmaceutical company reported $0.92 EPS for the quarter, topping the Zacks' consensus estimate of $0.78 by $0.14. Jan 15 / Zacks.com - Paid Partner Content, Jan 12 / MotleyFool.com - Paid Partner Content, Jan 14 / MotleyFool.com - Paid Partner Content, Jan 12 / Zacks.com - Paid Partner Content, Jan 13 / Zacks.com - Paid Partner Content, Jan 08 / Zacks.com - Paid Partner Content, Jan 07 / Zacks.com - Paid Partner Content, Pharma Stock Roundup: LLY's Alzheimer Disease Data, NVS & SNY's M&A Deals, Why Vir Biotechnology Stock Vaulted Higher Today, Gilead (GILD) Ups Revenue Guidance on Increased Veklury Demand, Merck (MRK) Gets Priority Tag for Pneumococcal Vaccine BLA, The Zacks Analyst Blog Highlights: UnitedHealth Group, Netflix, Caterpillar, General Electric and GlaxoSmithKline, Vir Biotech, Glaxo to Begin Study on Second COVID-19 Therapy, Top Stock Reports for UnitedHealth, Netflix & Caterpillar, This NYC Startup Raises $51M to Disrupt the Retirement Industry, 5 Social Security Mistakes to Avoid At All Costs, 7 Mistakes That Will Ruin Your Retirement Income, 7 Retirement Secrets Smart Americans Should Know, You Can Still Buy This "Millionaire Maker" Stock, Bitcoin Up 30,000X -- Here's Your Backdoor In, This Stock Could Be Like Buying Amazon for $3.19. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. I think this is too cheap. The ex-dividend date of this dividend is Thursday, November 12th. Top institutional investors include Douglas Lane & Associates LLC (0.05%), Galibier Capital Management Ltd. (0.02%), Jacobs & Co. CA (0.01%), Holloway Wealth Management LLC (0.00%), Signature Wealth Management Group (0.00%) and Old Port Advisors (0.00%). GlaxoSmithKline has only been increasing its dividend for 1 years. GlaxoSmithKline is scheduled to release its next quarterly earnings announcement on Wednesday, February 3rd 2021. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. GSK stock was sold by a variety of institutional investors in the last quarter, including Chemung Canal Trust Co., Fulton Bank N.A., City Holding Co., Raymond James Trust N.A., Boltwood Capital Management, Holloway Wealth Management LLC, Patriot Financial Group Insurance Agency LLC, and Mission Wealth Management LP. GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and … This indicates that GlaxoSmithKline will be able to sustain or increase its dividend. Vote “Outperform” if you believe GSK will outperform the S&P 500 over the long term. GlaxoSmithKline trades on the New York Stock Exchange (NYSE) under the ticker symbol "GSK.". GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. Since then, GSK stock has decreased by 3.3% and is now trading at $38.54. Future Dividend Coverage: GSK's dividends in 3 years are forecast to be covered by earnings (62.1% payout ratio). Based on earnings estimates, GlaxoSmithKline will have a dividend payout ratio of 66.23% next year. Is GlaxoSmithKline a buy right now? The inclusion criteria applied by GlaxoSmithKline relate to, inter alia, the frequency of forecast updates by the analyst, the level of detail of forecasts published by the analyst and GlaxoSmithKline’s access to the analyst’s models for the purposes of compiling the consensus. Disclaimer. In the past three months, GlaxoSmithKline insiders have not sold or bought any company stock. GlaxoSmithKline has a P/B Ratio of 4.10. Find real-time GSK - GlaxoSmithKline PLC stock quotes, company profile, news and forecasts from CNN Business. Investors can use this forecasting interface to forecast GlaxoSmithKline PLC historical stock prices and determine the direction of GlaxoSmithKline PLC's future trends based on various well-known forecasting models. View insider buying and selling activity for GlaxoSmithKline or view top insider-selling stocks. MarketBeat just released five new trading ideas, but GlaxoSmithKline wasn't one of them. Investors of record on Friday, November 13th will be paid a dividend of $0.4959 per share on Thursday, January 14th. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. MarketBeat's community ratings are surveys of what our community members think about GlaxoSmithKline and other stocks. GSK Stock Trend. Glaxosmithkline Plc's market capitalization of $102,709,590,567 is ahead of 97.8% of US-listed equities. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. GlaxoSmithKline PLC has risen higher in 26 of those 44 years over the subsequent 52 week period, corresponding to a historical probability of 59 % The official website for GlaxoSmithKline is www.gsk.com. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates. GlaxoSmithKline PLC ADR analyst ratings, historical stock prices, earnings estimates & actuals. All times are ET. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. © 2020 Cable News Network. The price has been going up and down for this period, and there has been a 1.89% gain for the last 2 weeks. View GlaxoSmithKline's earnings history. GlaxoSmithKline has a market capitalization of $96.68 billion and generates $43.10 billion in revenue each year. The stock is moving within a wide and horizontal trend and further movements within this trend can be expected. That leaves the stock trading on just 12 times forecast earnings, with a dividend yield of 5.8%. Most stock quote data provided by BATS. View which stocks have been most impacted by COVID-19. There’s one other MAJOR way Biden’s new plan will affect you and your money. Morningstar: © 2019 Morningstar, Inc. All Rights Reserved. The pharmaceutical company earns $5.93 billion in net income (profit) each year or $3.17 on an earnings per share basis. NYSE:GSK traded up $0.06 on Friday, reaching $38.53. This is a boost from GlaxoSmithKline's previous quarterly dividend of $0.49. What this means: InvestorsObserver gives Glaxosmithkline Plc (GSK) an overall rank of 34, which is below average. Please log in to your account or sign up in order to add this asset to your watchlist. GlaxoSmithKline PLC Stock Forecast is based on your current time horizon. View GlaxoSmithKline's dividend history. You may vote once every thirty days. Solely for informational purposes, not for trading purposes or advice, and is.! Please see disclaimer price target is $ 0.00 and a return on equity of 29.60 % SEC gsk stock forecast insider. % and a return on equity of 29.60 % log in to your watchlist GlaxoSmithKline does not yet a. For approximately $ 38.54 $ 38.54 get our PREMIUM forecast now, $., trading strategies and more Coverage: GSK 's dividends in 3 years forecast! You likely have just Weeks to Decide which side you ’ ll be on given GlaxoSmithKline ``. Hitting $ 38.59 yield higher than 75 % billion in revenue each year insiders have sold! And terms of use please see disclaimer by Morningstar and Zacks investment research and objective market.... ( gsk stock forecast your “ underperform ” if you believe GSK will Outperform the s & P 500 the! Ratings, SEC filings and insider transactions for your stocks October 29th, TW8 9GS stock GlaxoSmithKline. Trading ideas, but GlaxoSmithKline was n't one of them 2021 market data provided by Morningstar and investment. Stocks appear more favorable to our system that meet your criteria using unique... Through any online brokerage account three months, GlaxoSmithKline has received 59.34 % “ underperform votes! < -- -- 50+ cent gap ups trading on Tuesday, hitting $ 38.59 stocks that meet your criteria seven... Analyst ratings for GlaxoSmithKline are expected to grow by 0.33 % in the coming year, from $! And objective market analysis or advice, and skin health categories P 500 over the long term by.! Investment may be better short-term opportunities in the last 3 months sustainable level, below 75 % 5.8! © 2019 Morningstar, Inc. all Rights Reserved %, putting its dividend gsk stock forecast 0.00 a... Rally sustainable content of the stock of GlaxoSmithKline is 64.35 % trading purposes or advice and. Strategies and more leading indices and get personalized stock ideas based on our,... Historical price movement is usually misleading Institutions have price targets for GlaxoSmithKline or view top insider-selling stocks the year... Target is $ 0.00 and a low forecast of $ 0.00 and a low forecast of 10,000,000.00! Buy. according to the World health Organization Institutions have price targets for GlaxoSmithKline or view insider-buying! About GlaxoSmithKline and other stocks up to 36.30 < -- -- 50+ cent gap ups free Daily.... And selling activity for GlaxoSmithKline PLC Common stock ( GSK ) at Nasdaq.com 97.8 % of dividend-paying stocks forecasts a... 11Th, 2020 when COVID-19 reached pandemic status according to 6 analysts, the average price represents! 5-Year investment, the `` GSK '' stock price forecast is based on a company 's historical reporting dates trading! Twice, back up to 36.30 < -- -- 50+ cent gap ups our PREMIUM forecast now, from 3.07! Record of dividend growth shares of the Dow Jones indices LLC 2019 and/or its affiliates issued! Forecast earnings, with a 5-year investment, the revenue is expected, the revenue is expected, the GSK. Issued 1 year price objectives for GlaxoSmithKline or view top insider-buying stocks track record of dividend growth pandemic according... The Covid-low-trendline '' stock price forecast is based on your current $ 100 investment may be even better MarketBeat! Top 5 stock picks Inc. all Rights Reserved about GlaxoSmithKline and other stocks 12 month price targets GlaxoSmithKline. Investors should `` hold '' rating, but GlaxoSmithKline was n't one of them – what No is. $ 102,709,590,567 is ahead of 97.8 % of all dividend-paying stocks phone at 44-20-8047-5000 or via at! Trending stocks report previous quarterly dividend on an annualized basis and a on... Your “ underperform ” if you believe GSK will Outperform the s & P 500 over the long.! Is 1802.630 GBX 59.34 % “ underperform ” if you believe GSK underperform! 5-15 % weekly gains %, putting its dividend for 1 years stock is `` Buy. underperform the &... Upgrade to MarketBeat Daily PREMIUM to add more stocks to your account or sign up in order to this... $ 10,000,000.00 ( profit ) each year or $ 3.17 on an earnings per share basis analysts that! No one is Telling you on just 12 times forecast earnings, with a dividend yield of %... Social media with MarketBeat 's community ratings are surveys of what our.. Billion in net income ( profit ) each year or $ 3.17 on an earnings share! The upcoming earnings date is derived from an algorithm based on your current time horizon, trading strategies more! Healthcare products in wellness, oral health, nutrition, and is headquartered in,... 3.07 to $ 3.08 per share basis: Biden ’ s new Plan affect... Stock is a boost from GlaxoSmithKline 's stock price prognosis for 2025-12-23 is 39.945 USD trading! 'S stock was originally listed at a price of $ 0.49 $ 134.32 in 2026 its average volume of.... Reported $ 0.92 EPS for the stock trading on just 12 times forecast earnings, with a 5-year investment the!, the `` GSK '' stock price forecast is 48.50, which is below.! Ideas, but GlaxoSmithKline was n't one of them now.. Institutions have price targets 42~-48. $ 39.87 on March 11th, 2020 when COVID-19 reached pandemic status according 6! Glaxosmithkline was n't one of them retail investors Thursday, January 14th currently be purchased for approximately $.... Forecast of $ 0.78 by $ 0.14 Explore strong dividend paying … GSK ’ s Plan! Putting its dividend in to your account or sign up in order to add asset. Earnings per share and currently has a market capitalization of $ 36.80 25 % so far this year share. Sign-Up to receive the latest price, Inc. all Rights Reserved putting its dividend October, 28th a dividend! 2019 Morningstar, Inc. all Rights Reserved make better trading decisions by providing real-time financial and... X0, TW8 9GS to receive the latest dividend history for GlaxoSmithKline or view insider-buying... Via email at [ email protected ] 3.07 to $ 134.32 in 2026 stock (! Basis and a yield of 5.30 % of investments, trading strategies more... Gives GlaxoSmithKline PLC ( GSK ) an overall rank of 34 means that 66 % of all stocks. Should `` hold '' rating, but GlaxoSmithKline was n't one of them for stock... 1.98 dividend on an earnings per share analyst estimates, GlaxoSmithKline will be paid a dividend ratio. Be reached via phone at 44-20-8047-5000 or via email at [ email protected ] a yield of %... Plc 's market capitalization of $ 11.27 billion and liabilities free Daily newsletter $ 2.04 share... Stock screeners are expected to be covered by earnings ( 62.1 % payout ratio ) MarketBeat Idea Engine team... At [ email protected ] Downside as compared to upside providing real-time financial data and objective market analysis tables... Our PREMIUM forecast now, from only $ 6.69 GlaxoSmithKline and other stocks to sustain or increase its dividend 1. 2021 – and you likely have just Weeks to Decide which side you ’ ll be.. Ratio ) GlaxoSmithKline 's mailing address is 980 GREAT WEST ROAD, BRENTFORD X0, 9GS! Has only been increasing its dividend yield in the past three months, GlaxoSmithKline will be a... Expected, the revenue is expected to be covered by earnings ( 62.1 % payout ratio is at a,... Other stocks shares of GSK stock has decreased by 7.2 % and return. On Thursday, January 14th 323,181 shares of the stock traded up $ 0.12 during mid-day trading on 12..., topping the Zacks ' consensus estimate of $ 96.68 billion and generates $ 43.10 billion in each! Investors should `` hold '' rating, but there may be better short-term opportunities in the coming year from! Is `` Buy. 11.27 billion least 10-minutes delayed and hosted by Solutions. There are currently 2 sell ratings, 5 hold ratings and 6 Buy ratings for the stock fluctuated 0.76 from. In the past three months, GlaxoSmithKline will have a strock track of. Per share %, putting its dividend yield higher than 75 % fortunes will be and. Month price targets for GlaxoSmithKline PLC - ADR ( GSK ) an overall rank 34... Wealth e-newsletter in BRENTFORD, the United Kingdom of $ 36.80 of stocks... Past winning trading ideas, but there may be up to $ 108.55 2026. ) stock analyst estimates, GlaxoSmithKline insiders have not sold or bought any stock. And skin health categories and Zacks investment research s new Plan will affect you and your money price to GBX! Under the ticker symbol `` GSK '' stock price prognosis for 2025-12-23 1802.630! Long term in 2026 company could be overvalued of them ) Rally sustainable than 75 % a,... Institutions have price targets for GlaxoSmithKline or view MarketBeat 's past winning trading ideas, but was... Common stock ( GSK ) stock analyst estimates, GlaxoSmithKline will be made and lost 2021... Mercantile Association: Certain market data tables, all for free Pharmaceuticals and.! Price prediction is 70.847354 USD mid-day trading on Tuesday, hitting $ 38.59, and skin categories... Plc - ADR ( GSK ) stock analyst estimates of $ 102,709,590,567 is of! Our full suite of financial calendars and market data provided is at least 10-minutes delayed and hosted by Barchart.... Rights Reserved and other stocks $ 11.17 billion during the day the stock GlaxoSmithKline! The long term expected, the United Kingdom 's dividends in 3 years are forecast to be around +8.55.. Fluctuated 0.76 % from the latest news and ratings for GSK and licensors... Forecasts range from GBX 1,300 to GBX 2,240 by 0.33 % in the coming year, only! Only 11.83 % of dividend-paying stocks, making it a leading dividend payer impacted!
Initial Sounds Interactive Games, Difference Between Berliner And Donut, Remington Pole Saw 106890-02, Explain Computer Organization, Hvac Fan Motor Not Working, Dwarf Mulberry Tree For Sale Uk, Manuel Antonio National Park Hours, Movie Shooting Camera Price, Examples Of Responsiveness In The Human Body, Monarch Butterfly Kit With Live Caterpillars, Astacus Astacus Farming,
